Guyton, J. R., Weinstock, R. S., Mazzone, T., Goldberg, R. B., Polis, A., Rosenberg, E., & Tershakovec, A. M. (2007). PO23-734 INFLUENCE OF AGE, GENDER, AND ETHNICITY ON TREATMENT EFFECTS IN THE VYTAL TRIAL OF EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN IN TYPE 2 DIABETICS. In Atherosclerosis Supplements (Vol. 8, pp. 195–196). Elsevier BV. https://doi.org/10.1016/s1567-5688(07)71744-0

Guyton, J. R., R. S. Weinstock, T. Mazzone, R. B. Goldberg, A. Polis, E. Rosenberg, and A. M. Tershakovec. “PO23-734 INFLUENCE OF AGE, GENDER, AND ETHNICITY ON TREATMENT EFFECTS IN THE VYTAL TRIAL OF EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN IN TYPE 2 DIABETICS.” In Atherosclerosis Supplements, 8:195–96. Elsevier BV, 2007. https://doi.org/10.1016/s1567-5688(07)71744-0.

Guyton JR, Weinstock RS, Mazzone T, Goldberg RB, Polis A, Rosenberg E, et al. PO23-734 INFLUENCE OF AGE, GENDER, AND ETHNICITY ON TREATMENT EFFECTS IN THE VYTAL TRIAL OF EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN IN TYPE 2 DIABETICS. In: Atherosclerosis Supplements. Elsevier BV; 2007. p. 195–6.

Guyton, J. R., et al. “PO23-734 INFLUENCE OF AGE, GENDER, AND ETHNICITY ON TREATMENT EFFECTS IN THE VYTAL TRIAL OF EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN IN TYPE 2 DIABETICS.” Atherosclerosis Supplements, vol. 8, no. 1, Elsevier BV, 2007, pp. 195–96. Crossref, doi:10.1016/s1567-5688(07)71744-0.

Guyton JR, Weinstock RS, Mazzone T, Goldberg RB, Polis A, Rosenberg E, Tershakovec AM. PO23-734 INFLUENCE OF AGE, GENDER, AND ETHNICITY ON TREATMENT EFFECTS IN THE VYTAL TRIAL OF EZETIMIBE/SIMVASTATIN VS. ATORVASTATIN IN TYPE 2 DIABETICS. Atherosclerosis Supplements. Elsevier BV; 2007. p. 195–196.